Tag Archive for: Series A

Enhanc3D Genomics raises £10 million in Series A financing to advance GenLink3D proprietary technology platform

Cambridge, UK, 20th October 2022: Enhanc3D Genomics (“Enhanc3D”), a functional genomics company unlocking the full potential of the human 3D genome to transform therapeutic development, today announces it has raised £10 million in Series A financing to accelerate the development of its proprietary technology platform – “GenLink3DTM”. The financing was led by BGF and Parkwalk Advisors, […]

Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers

Oversubscribed financing co-led by HealthCap and EQT Life Sciences (formerly LSP); joined by Pureos Bioventures Developing novel drugs for systemic targeted radiation therapy (STRT) Proceeds will be used to advance lead radiopharmaceutical product, satoreotide, for the treatment of neuroendocrine cancers and certain other aggressive, hard-to-treat cancers Led by industry veteran Manfred Rüdiger as CEO, and world-renowned […]

TargED raises €39 million in a series A investment round

TargED is extremely pleased and proud to have raised €39 million in a Series A investment round! Together with an international investor syndicate  we’ll pursue our common goal: to bring Microlyse into clinical development! Read press release

Amber Implants Closes US$10 M Series A Financing

The Hague, Netherlands, 19 January 2022: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces the successful closing of its US$10 million Series A Financing in 2021. The round was co-led by the founders and existing venture capital investors, with participation from angel investors and non-dilutive government funding. […]

Novo Holdings Leads US$21M Series A Financing in BI-OMILQ

Funds will be used to support the development of pioneering mammary biotechnology to bring a novel infant feeding option to market that better meets infants’ nutritional needs Syndicate includes leading clean tech and food tech investors Copenhagen, Denmark – 20 October 2021 – Novo Holdings, a leading international life science investor, today announces it has led […]